ETH
ABBV icon

Exos TFP Holdings’s AbbVie ABBV Stock Holding History

Exos TFP Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,317
Closed -$2.28M – 244
2023
Q1 		$2.28M Buy
14,317
+7,659
+115% +$1.17M 0.58% 56
2022
Q4 		$1.08M Buy
6,658
+3,833
+136% +$588K 0.3% 96
2022
Q3 		$379K Buy
+2,825
New +$405K 0.17% 146

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exos TFP Holdings's ABBV Position: Q2 2023 in Review

Exos TFP Holdings sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 14,317 shares — an estimated $2.28M sold.

Exos TFP Holdings first reported a position in ABBV in Q3 2022 and held it in 3 quarters. The position peaked at $2.28M in Q1 2023. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Exos TFP Holdings reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 14,317 AbbVie shares in Q2 2023, an estimated $2.28M.
  • Exos TFP Holdings first reported a position in AbbVie in Q3 2022 and held it in 3 quarters.
  • Exos TFP Holdings's AbbVie position peaked at $2.28M in Q1 2023.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.